2000
DOI: 10.2337/diabetes.49.6.926
|View full text |Cite
|
Sign up to set email alerts
|

Effects of glucosamine infusion on insulin secretion and insulin action in humans.

Abstract: Glucose toxicity (i.e., glucose-induced reduction in insulin secretion and action) may be mediated by an increased flux through the hexosamine-phosphate p a t hw a y. Glucosamine (GlcN) is widely used to accelerate the hexosamine pathway flux, independently of glucose. We tested the hypothesis that GlcN can aff e c t insulin secretion and/or action in humans. In 10 healthy subjects, we sequentially performed an intravenous g l ucose (

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
104
0
3

Year Published

2000
2000
2017
2017

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 139 publications
(113 citation statements)
references
References 42 publications
3
104
0
3
Order By: Relevance
“…In muscle the level of UDP-GlcN was positively correlated with the decrease in glucose infusion rate [46]. Interestingly, in humans, glucosamine infusion impairs insulin-mediated glucose utilisation under hyperglycaemia, but not at euglycaemia [50] as it does in rats [6,7]. Taken together, it seems that glucosamine does model high-glucose-induced insulin resistance in muscle and it would be interesting to investigate whether high glucose also inhibits insulin-mediated capillary recruitment.…”
Section: Discussionmentioning
confidence: 95%
“…In muscle the level of UDP-GlcN was positively correlated with the decrease in glucose infusion rate [46]. Interestingly, in humans, glucosamine infusion impairs insulin-mediated glucose utilisation under hyperglycaemia, but not at euglycaemia [50] as it does in rats [6,7]. Taken together, it seems that glucosamine does model high-glucose-induced insulin resistance in muscle and it would be interesting to investigate whether high glucose also inhibits insulin-mediated capillary recruitment.…”
Section: Discussionmentioning
confidence: 95%
“…In a standard IVGTT analysed with minimal models, sampling is prolonged until 180-240 min, and glucose thresholds and basal insulin secretion rates are based on the levels attained at the end of the test [13,14]. Thus, glucose threshold and basal insulin secretion in the minimal model analysis of the IVGTTs included in the present study were higher than they might have been if sampling had been continued for an additional 120-180 min.…”
Section: Modelmentioning
confidence: 91%
“…In the last two decades, mathematical modelling of betacell-derived hormone concentration over time has progressed considerably, enabling one to safely distinguish between early and late phases of insulin secretion under experimental reference conditions, such as IVGTT [12][13][14] and hyperglycaemic clamp [11]. Recently, we introduced a parsimonious model of C-peptide secretion during OGTT as a tool for the physiological assessment of beta cell function [15].…”
Section: Introductionmentioning
confidence: 99%
“…Intravenous administration of GlcN in rats induces much higher plasmatic concentrations than oral administration: infusion of 30.45 g of GlcN produced GlcN concentrations of ϳ1.42 mmol/liter (51). Because of the limited information regarding HBP flux, which is accelerated by GlcN infusion in humans, in vivo physiological dosing might be an important issue to be addressed in the future.…”
Section: Discussionmentioning
confidence: 99%